Verapamil increases outflow facility in the human eye

Experimental Eye Research

Volumn 61, Issue 5, 1995, Pages 565-567

  Erickson, Kristine A ^a   Schroeder, Alison ^a   Netland, Peter A ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Calcium channel blockers; Calcium channels; Calcium signaling; Human eye; Outflow facility; Verapamil

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM CHANNEL; VERAPAMIL;

AQUEOUS HUMOR OUTFLOW; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REGIONAL PERFUSION;

AGED; ANTERIOR EYE SEGMENT; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; INTRAOCULAR PRESSURE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VERAPAMIL;

EID: 0028874389     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4835(05)80050-8     Document Type: Article

References (15)

1. Abelson, M., Gilbert, C., and Smith, L. (1988). Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil. Am. J. Ophthalmol. 105, 155-9.
2. Epstein, D. L., Freddo, T. F., Bassett-Chu, S., Chung, M. and Karageuzian, L. (1987). Influence ofethacrynic acid on outflow facility in the monkey and calf eye. Invest. Ophthalmol. Vis. Sei. 28, 2067-75.
3. Erickson-Lamy, K., Rohen, J. W. and Grant, W. M. (1991). Outflow facility studies in the perfused human ocular anterior segment. Exp. Eye Res. 52, 723-31.
4. Erickson-Lamy, K. and Nathanson, J. A. (1992). Epinephrine increases facility of outflow and cyclic AMP content in the human eye in vitro. Invest. Ophthalmol. Vis. Sei. 33, 2672-8.
5. Erickson, K., Schroeder, A. and Epstein, D. L. (1992). Ethacrynic acid induces reversible shape and cyto-skeletal changes in cultured cells. Invest. Ophthalmol. Vis. Sei. 33, 2631-0.
6. Ettl, A., Daxer, A. and Hoffman, U. (1993). Calcium channel blockers in the management of low-tension and open angle glaucoma. Am. J. Ophthalmol. 116[letter] 778.
7. 2+ antagonist receptor. Trends Pharmacol. 10, 297-301.
8. Goyal, J. K., Khilnani, G., Sharma, D. P. and Singh, J. (1989). The hypotensive effect of verapamil HC1 eye drops on ocular hypertension. Ind. J. Ophthalmol. 37(4), 176-8.
9. 2 EDTA on the outflow routes for aqueous humor in monkeys. Exp. Eye Res. 44, 171-9O.
10. Hurwitz, L. (1986). Pharmacology of calcium channels and smooth muscle. In Annual Review of Pharmacology and Toxicology. (Ed. George, R., Okun, R. and Cho, A. K.) p. 225. Palo Alto: Annual Reviews Inc.
11. Kreuter, U., Muhlemann, M., Vogt, E. and Wohlwend, M. C. (1990). Verapamil and hypertension: multicenter study of the efficacy and tolerance of delayed action verapamil in the treatment of essential hypertension. Rev. Med. Suisse Romande. 110(6), 551-8.
12. Netland, P. A. and Erickson, K. A. (1995). Calcium channel blockers in glaucoma management. Ophthalmol. Clin. North Am. 8, 327-34
13. Netland, P. A., Grosskreutz, C. L., Feke, G. T. and Hart, L. J. (1995). Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker. Am. J. Ophthalmol. 119 (6), 694-700.
14. O'Brien, E. T., Roberts, B. C. and Epstein, D. L. (1993). Cytosolic calcium levels in endothelial cells after exposure to ethacrynic acid. Invest. Ophthalmol. Vis. Sei. 34 (suppl.), 923.
15. Wangemann, P., Shiga, N., Welch, C. and Marcus, D. C. (1992). Evidence for the involvement of a K+ channel in isosmotic cell shrinking in vestibular dark cells. Am. J. Physiol (US.) 263, C616-22.